LentiV_Puro Citations (3)
Originally described in: Salt-Inducible Kinase inhibition suppresses acute myeloid leukemia progression in vivo.Tarumoto Y, Lin S, Wang J, Milazzo JP, Xu Y, Lu B, Yang Z, Wei Y, Polyanskaya S, Wunderlich M, Gray NS, Stegmaier K, Vakoc CR Blood. 2019 Nov 1. pii: 422697. doi: 10.1182/blood.2019001576. PubMed Journal
Articles Citing LentiV_Puro
| Articles |
|---|
| RNF43 G659fs is an oncogenic colorectal cancer mutation and sensitizes tumor cells to PI3K/mTOR inhibition. Fang L, Ford-Roshon D, Russo M, O'Brien C, Xiong X, Gurjao C, Grandclaudon M, Raghavan S, Corsello SM, Carr SA, Udeshi ND, Berstler J, Sicinska E, Ng K, Giannakis M. Nat Commun. 2022 Jun 8;13(1):3181. doi: 10.1038/s41467-022-30794-7. PubMed |
| Cloning BRD4 long isoform into overexpression vectors for stable overexpression of BRD4-L in mammalian cells. Drumond-Bock AL, Cybula M, Wang L, Wang L, Bieniasz M. STAR Protoc. 2022 Oct 26;3(4):101785. doi: 10.1016/j.xpro.2022.101785. eCollection 2022 Dec 16. PubMed |
| Control of Inflammatory Response by Tissue Microenvironment. Wu Z, Pope SD, Ahmed NS, Leung DL, Hajjar S, Yue Q, Anand DM, Kopp EB, Okin D, Ma W, Kagan JC, Hargreaves DC, Medzhitov R, Zhou X. bioRxiv [Preprint]. 2025 May 30:2024.05.10.592432. doi: 10.1101/2024.05.10.592432. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.